Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
ASCO News - Magrolimab in Combination with Azacitidine Demonstrates Durable Activity in Untreated MDS & AML
May 29, 2020 - FOSTER CITY, Calif. - Gilead Sciences, Inc. (Nasdaq: GILD) today announced updated results from a single-arm, open-label Phase 1b trial…
Patient Education Webcasts
Chronic Lymphocytic Leukemia (CLL): What Are My Treatment Options?
Gilead to Acquire Forty Seven for $4.9 Billion
FOSTER CITY, Calif. & MENLO PARK, Calif., March 2, 2020 - Gilead Sciences, Inc. (Nasdaq: GILD) and Forty Seven, Inc. (Nasdaq: FTSV) announced today th…
Kymera Therapeutics Announces $102 Million Series C Financing
Cambridge, Mass (March 12, 2020) – Kymera Therapeutics Inc., a biotechnology company pioneering targeted protein degradation to invent breakthrough pr…
Ryvu Therapeutics receives Orphan Drug Designation from FDA
KRAKOW, Poland, March 28, 2020 – Ryvu Therapeutics (WSE: RVU), a clinical-stage biopharmaceutical company developing novel small molecule therapies th…
Media resources
Email
Contact us for inquiries and interview requests.
Press Kit
Explore details for journalists and media outlets.
Brand Center
Access approved logos, guidelines, and other assets.